Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: Pathophysiological correlates and prognostic evaluation

Heart

Volumn 89, Issue 4, 2003, Pages 411-416

  Cohen, N ^a   Almoznino Sarafian, D ^a   Zaidenstein, R ^b   Alon, I ^a   Gorelik, O ^a   Shteinshnaider, M ^a   Chachashvily, S ^a   Averbukh, Z ^b   Golik, A ^b   Chen Levy, Z ^b   Modai, D ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; MAGNESIUM;

AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; FEMALE; FEVER; HUMAN; HYPERMAGNESEMIA; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPONATREMIA; KIDNEY FAILURE; MAGNESIUM BLOOD LEVEL; MAGNESIUM DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; OBSERVATION; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SUDDEN DEATH; SURVIVAL;

EID: 0037381981     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.4.411     Document Type: Article

References (29)

1. Wester PO. Electrolyte balance in heart failure and the role for magnesium ions. Am J Cardiol 1992;70:44-49C.
2. Al-Ghamdi SMG, Cameron EC, Sutton RAL. Magnesium deficiency: pathophysiologic and clinical overview. Am J Kidney Dis 1994;24:737-52.
3. Reinhart RA. Magnesium metabolism: a review with special reference to the relationship between intracellular content and serum levels. Arch Intern Med 1988;148:2415-20.
4. Whang R, Hampton EM, Whang DD. Magnesium homeostasis and clinical disorders of magnesium deficiency. Ann Pharmacother 1994;28:220-6.
5. Gottlieb SS. Importance of magnesium in congestive heart failure. Am J Cardiol 1989;63:39-42G.
6. Leier CV, Dei Cas L, Metra M. Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. Am Heart J 1994;128:564-74.
7. Douban S, Brodsky MA, Whang DD, et al. Significance of magnesium in congestive heart failure. Am Heart J 1996;132:664-71.
8. Davies DL, Fraser R. Do diuretics cause magnesium deficiency? Br J Clin Pharmacol 1993;36:1-10.
9. Ralston MA, Murnane MR, Kelley RE, et al. Magnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure. Circulation 1989;80:573-80.
10. Dyckner T, Wester PO. Plasma and skeletal muscle electrolytes in patients on long-term diuretic therapy for arterial hypertension and/or congestive heart failure. Acta Med Scand 1987;222:231-6.
11. Eichhorn EJ, Tandon PK, DiBianco R, et al. Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE study. J Am Coll Cardiol 1993;21:634-40.
12. Gottlieb SS, Baruch L, Kukin ML, et al. Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. J Am Coll Cardiol 1990;16:827-31.
13. Ceremuzynski L, Gebalska J, Wolk R, et al. Hypomagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation. J Intern Med 2000;247:78-86.
14. Teerlink JR, Massie BM. The role of beta-blockers in preventing sudden death in heart failure. J Card Fail 2000;6(2 suppl 1):25-33.
15. Block G, Subar AF. Estimates of nutrient intake from a food frequency questionnaire. J Am Diet Assoc 1992;92:969-77.
16. Dixon WJ, ed. BMDP statistical software. Los Angeles: University of California Press, 1992.
17. Kjaer A, Hesse B. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives. Clin Physiol 2001;21:661-72.
18. Whang R, Oei TO, Aikawa JK, et al. Predictors of clinical hypomagnesemia. Hypokalemia, hypophosphatemia, hyponatremia, and hypocalcemia. Arch Intern Med 1984;144:1794-6.
19. Lum G. Hypomagnesemia in acute and chronic care patient populations. Am J Clin Pathol 1992;97:827-30.
20. D'Erasmo E, Celi FS, Acca M, et al. Hypocalcemia and hypomagnesemia in cancer patients. Biomed Pharmacother 1991;45:315-17.
21. Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med 1996;156:1143-8.
22. DiCarlo LA, Morady F, de Buitleir M, et al. Effects of magnesium sulfate on cardiac conduction and refractoriness in humans. J Am Coll Cardiol 1986;7:1356-6.
23. Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993;270:2590-7.
24. Gettes LS. Electrolyte abnormalities underlying lethal and ventricular arrhythmias. Circulation 1992;85(suppl 1):170-6.
25. Cohen N, Alon I, Aimoznino-Sarafian D, et al. Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failure. Clin Cardiol 2000;23:433-6.
26. Dorup I, Skajaa K, Clausen T, et al. Reduced concentrations of potassium, magnesium, and sodium-potassium pumps in human skeletal muscle during treatment with diuretics. BMJ 1988;296:455-8.
27. Bashir Y, Sneddon JF, Staunton HA, et al. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. Am J Cardiol 1993;72:1156-62.
28. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med 1999;341:709-17.
29. Soberrnan JE, Weber KT. Spironolactone in congestive heart failure. Curr Hypertens Rep 2000;2:451-6.